- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有220家主力机构披露2025-06-30报告期持股数据，持仓量总计5.20亿股，占流通A股55.26%
- 波段诊断：
-
技术面诊股
诊断结果：4.6技术面打败了13%的股票
技术面评分前10的股票
近期的平均成本为17.37元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为17.37元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"17.37","date":1758095455,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。
[{"date":"2025.09.18","stock":"-0.75","trade":"-0.43","ind":"-1.06"},{"date":"2025.09.17","stock":"0.23","trade":"-0.76","ind":"1.16"},{"date":"2025.09.16","stock":"-0.34","trade":"-0.13","ind":"0.45"},{"date":"2025.09.15","stock":"-1.47","trade":"-0.30","ind":"0.63"},{"date":"2025.09.12","stock":"-1.17","trade":"0.40","ind":"-0.43"},{"date":"2025.09.11","stock":"0.22","trade":"0.93","ind":"3.36"},{"date":"2025.09.10","stock":"-3.04","trade":"-0.72","ind":"0.38"},{"date":"2025.09.09","stock":"0.00","trade":"-1.80","ind":"-1.23"},{"date":"2025.09.08","stock":"2.22","trade":"0.58","ind":"0.61"},{"date":"2025.09.05","stock":"2.10","trade":"2.42","ind":"3.89"},{"date":"2025.09.04","stock":"1.61","trade":"-2.38","ind":"-2.83"},{"date":"2025.09.03","stock":"-1.42","trade":"-0.53","ind":"-0.65"},{"date":"2025.09.02","stock":"-0.79","trade":"-1.36","ind":"-2.14"},{"date":"2025.09.01","stock":"0.23","trade":"3.19","ind":"1.05"},{"date":"2025.08.29","stock":"-0.17","trade":"1.06","ind":"0.99"},{"date":"2025.08.28","stock":"-0.95","trade":"-0.40","ind":"2.25"},{"date":"2025.08.27","stock":"-1.86","trade":"-2.79","ind":"-1.43"},{"date":"2025.08.26","stock":"0.16","trade":"-0.99","ind":"0.26"},{"date":"2025.08.25","stock":"1.05","trade":"1.41","ind":"2.26"},{"date":"2025.08.22","stock":"0.11","trade":"-0.02","ind":"2.07"},{"date":"2025.08.21","stock":"0.33","trade":"0.11","ind":"-0.06"}]
派林生物,深证成指,生物制品指数
压力支撑
该股压力位为17.31元，支撑位为17.14元。
[{"text":"\u538b\u529b\u4f4d","value":"17.31","date":1758124800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"17.14","date":1758124800,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.2资金面打败了27%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：09月18日 17:19
| 机构今日流向(万元) | -2882.76 | 机构5日流向(万元) | -9204.10 |
| 机构10日流向(万元) | -11780.97 | 机构20日流向(万元) | -33015.80 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加12462.90万股，其中基金净增仓34家，主力净减仓49家，请投资者中长期谨慎为宜。
截止2025-06-30，共220家主力机构（基金212家，一般法人7家，社保基金1家），持仓量总计51984.18万股，占流通A股55.26%
其中，基金持仓与2024-12-31相比：
增仓：73家 ，增持 1136.50万股
减仓：39家 ，减持 2460.64万股
新出现在主力名单中：95家 ，持有5723.62万股
从主力名单中消失：144家 ，原持有4275.21万股
其中，基金持仓与2024-12-31相比：
增仓：73家 ，增持 1136.50万股
减仓：39家 ，减持 2460.64万股
新出现在主力名单中：95家 ，持有5723.62万股
从主力名单中消失：144家 ，原持有4275.21万股
消息面诊股
诊断结果：5.5消息面打败了4%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 派林生物：9月17日获融资买入1496.24万元，
2025-09-18 - 派林生物：9月16日获融资买入2134.07万元
2025-09-17 - 派林生物：9月15日获融资买入2241.38万元
2025-09-16 - 47亿！国药集团再次出手收购一家血液制品头部企业
2025-09-15 - 派林生物：9月12日获融资买入4862.87万元
2025-09-15 - 派林生物又“卖身”，中国生物吞下血液制品龙头
2025-09-12 - 47亿！国药系再拿下一家上市公司
2025-09-12 - 行业周报|生物制品指数跌-0.64%, 跑输上证指
2025-09-12 - 派林生物：9月11日获融资买入3785.39万元，
2025-09-12 - 47亿！国药系又完成一起并购
2025-09-11
消息列表
| 一般消息 | 资产重组 | 公司股权转让 | 2025-09-10 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-22 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-22 |
| 一般消息 | 募资投向 | 2025-08-22 | |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-05-12 |
| 利好 | 分红转增 | 10转3股派3.5元(含税) | 2025-04-24 |
| 利好 | 分红转增 | 10派1.5元(含税) | 2024-10-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.1行业面打败了72%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.09.18","price":"-1.06","value":"-0.43"},{"date":"2025.09.17","price":"1.16","value":"-0.76"},{"date":"2025.09.16","price":"0.45","value":"-0.13"},{"date":"2025.09.15","price":"0.63","value":"-0.30"},{"date":"2025.09.12","price":"-0.43","value":"0.40"},{"date":"2025.09.11","price":"3.36","value":"0.93"},{"date":"2025.09.10","price":"0.38","value":"-0.72"},{"date":"2025.09.09","price":"-1.23","value":"-1.80"},{"date":"2025.09.08","price":"0.61","value":"0.58"},{"date":"2025.09.05","price":"3.89","value":"2.42"},{"date":"2025.09.04","price":"-2.83","value":"-2.38"},{"date":"2025.09.03","price":"-0.65","value":"-0.53"},{"date":"2025.09.02","price":"-2.14","value":"-1.36"},{"date":"2025.09.01","price":"1.05","value":"3.19"},{"date":"2025.08.29","price":"0.99","value":"1.06"},{"date":"2025.08.28","price":"2.25","value":"-0.40"},{"date":"2025.08.27","price":"-1.43","value":"-2.79"},{"date":"2025.08.26","price":"0.26","value":"-0.99"},{"date":"2025.08.25","price":"2.26","value":"1.41"},{"date":"2025.08.22","price":"2.07","value":"-0.02"},{"date":"2025.08.21","price":"-0.06","value":"0.11"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 迈威生物 | 49.51% | 8.16% | 5.2分 |
| 2 | 荣昌生物 | 32.88% | -5.06% | 6.0分 |
| 3 | 长春高新 | 25.92% | 4.78% | 6.5分 |
| 4 | ST未名 | 16.54% | 14.88% | 5.3分 |
| 5 | 西藏药业 | 14.09% | -4.31% | 6.3分 |
| 6 | 义翘神州 | 11.27% | 2.68% | 5.6分 |
| 8 | 甘李药业 | 7.80% | -2.31% | 6.1分 |
| 10 | 百普赛斯 | 3.33% | 2.64% | 4.9分 |
| 12 | *ST四环 | 1.75% | -1.28% | 4.6分 |
| 14 | 君实生物 | 0.82% | -4.19% | 5.7分 |
| 16 | 昊帆生物 | -2.19% | 5.04% | 5.9分 |
| 18 | 通化东宝 | -3.06% | -2.49% | 5.2分 |
| 20 | 派林生物 | -4.11% | -3.47% | 5.1分 |
| 22 | 天坛生物 | -4.95% | -1.46% | 5.4分 |
| 24 | 康泰生物 | -5.60% | -7.35% | 4.4分 |
| 26 | 成大生物 | -6.05% | -2.20% | 5.7分 |
| 28 | 东宝生物 | -6.93% | -1.05% | 5.7分 |
| 30 | 万泽股份 | -7.15% | -2.92% | 5.6分 |
| 32 | 金迪克 | -7.54% | -2.50% | 5.5分 |
| 34 | 卫光生物 | -7.71% | -3.27% | 5.0分 |
| 36 | 安科生物 | -7.83% | -0.37% | 4.8分 |
| 38 | 近岸蛋白 | -8.10% | -1.91% | 4.5分 |
| 40 | 艾迪药业 | -8.81% | -0.26% | 5.4分 |
| 42 | 百克生物 | -9.85% | -3.85% | 5.2分 |
| 44 | 博晖创新 | -10.39% | -2.53% | 5.0分 |
| 46 | 康华生物 | -12.01% | -0.94% | 5.5分 |
| 48 | 赛升药业 | -14.24% | -2.48% | 4.4分 |
| 50 | - | -14.94% | -0.12% | 分 |
| 52 | 凯因科技 | -17.72% | -0.07% | 5.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 21/72 ， 40/72。
[{"date":"2025-06-30","value":"2.98","vol":"-0.34"},{"date":"2025-03-31","value":"1.12","vol":"0.63"},{"date":"2024-12-31","value":"9.71","vol":"-0.24"},{"date":"2024-09-30","value":"7.11","vol":"1.37"},{"date":"2024-06-30","value":"4.35","vol":"0.72"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.98 | 1.12 | 9.71 | 7.11 | 4.35 |
| 行业(%) | -0.34 | 0.63 | -0.24 | 1.37 | 0.72 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"47.63","vol":"68.47"},{"date":"2025-03-31","value":"48.06","vol":"69.78"},{"date":"2024-12-31","value":"49.13","vol":"69.97"},{"date":"2024-09-30","value":"50.52","vol":"70.57"},{"date":"2024-06-30","value":"50.20","vol":"69.89"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
47.63 | 48.06 | 49.13 | 50.52 | 50.20 |
| 行业(%) | 68.47 | 69.78 | 69.97 | 70.57 | 69.89 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 42/72 ， 36/72。
[{"date":"2025-06-30","value":"-13.18","vol":"7036.72"},{"date":"2025-03-31","value":"-14.00","vol":"6246.12"},{"date":"2024-12-31","value":"14.00","vol":"48.20"},{"date":"2024-09-30","value":"37.49","vol":"178.44"},{"date":"2024-06-30","value":"60.23","vol":"19.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-13.18 | -14.00 | 14.00 | 37.49 | 60.23 |
| 行业(%) | 7036.72 | 6246.12 | 48.20 | 178.44 | 19.75 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-27.89","vol":"5.62"},{"date":"2025-03-31","value":"-26.95","vol":"-7.36"},{"date":"2024-12-31","value":"21.76","vol":"-10.38"},{"date":"2024-09-30","value":"66.38","vol":"-53.42"},{"date":"2024-06-30","value":"128.44","vol":"-9.25"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-27.89 | -26.95 | 21.76 | 66.38 | 128.44 |
| 行业(%) | 5.62 | -7.36 | -10.38 | -53.42 | -9.25 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，两项指标的行业排名分别为 29/72 ， 32/72。
[{"date":"2025-06-30","value":"0.11","vol":"0.14"},{"date":"2025-03-31","value":"0.04","vol":"0.06"},{"date":"2024-12-31","value":"0.30","vol":"0.29"},{"date":"2024-09-30","value":"0.21","vol":"0.22"},{"date":"2024-06-30","value":"0.13","vol":"0.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.11 | 0.04 | 0.30 | 0.21 | 0.13 |
| 行业(次) | 0.14 | 0.06 | 0.29 | 0.22 | 0.14 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.36","vol":"0.57"},{"date":"2025-03-31","value":"0.15","vol":"0.26"},{"date":"2024-12-31","value":"1.26","vol":"1.19"},{"date":"2024-09-30","value":"0.91","vol":"0.87"},{"date":"2024-06-30","value":"0.55","vol":"0.55"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.36 | 0.15 | 1.26 | 0.91 | 0.55 |
| 行业(次) | 0.57 | 0.26 | 1.19 | 0.87 | 0.55 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，居行业前列，两项指标的行业排名分别为 43/72 ， 44/72。
[{"date":"2025-06-30","value":"-12.56","vol":"-1392.00"},{"date":"2025-03-31","value":"-30.92","vol":"-47.52"},{"date":"2024-12-31","value":"12.33","vol":"-9.01"},{"date":"2024-09-30","value":"15.21","vol":"-29.47"},{"date":"2024-06-30","value":"23.51","vol":"-36875.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -12.56 | -30.92 | 12.33 | 15.21 | 23.51 |
| 行业 | -1392.00 | -47.52 | -9.01 | -29.47 | -36875.39 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.50","vol":"1.46"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.83","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"2.78","vol":"2.72"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 2.50 | - | 3.83 | - | 2.78 |
| 行业 | 1.46 | 0.00 | 2.00 | 0.00 | 2.72 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 27/72 ， 21/72。
[{"date":"2025-06-30","value":"3.67","vol":"6.75"},{"date":"2025-03-31","value":"4.19","vol":"7.90"},{"date":"2024-12-31","value":"3.74","vol":"6.83"},{"date":"2024-09-30","value":"4.06","vol":"7.16"},{"date":"2024-06-30","value":"3.72","vol":"7.04"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.67 | 4.19 | 3.74 | 4.06 | 3.72 |
| 行业 | 6.75 | 7.90 | 6.83 | 7.16 | 7.04 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.87","vol":"5.39"},{"date":"2025-03-31","value":"2.37","vol":"6.47"},{"date":"2024-12-31","value":"2.42","vol":"5.50"},{"date":"2024-09-30","value":"2.70","vol":"5.77"},{"date":"2024-06-30","value":"2.45","vol":"5.91"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.87 | 2.37 | 2.42 | 2.70 | 2.45 |
| 行业 | 5.39 | 6.47 | 5.50 | 5.77 | 5.91 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 32/72 ， 34/72。
[{"date":"2025-06-30","value":"13.04","vol":"26.08"},{"date":"2025-03-31","value":"12.94","vol":"25.48"},{"date":"2024-12-31","value":"14.37","vol":"25.46"},{"date":"2024-09-30","value":"13.57","vol":"24.92"},{"date":"2024-06-30","value":"13.89","vol":"24.62"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
13.04 | 12.94 | 14.37 | 13.57 | 13.89 |
| 行业(%) | 26.08 | 25.48 | 25.46 | 24.92 | 24.62 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.15","vol":"1.11"},{"date":"2025-03-31","value":"0.15","vol":"0.78"},{"date":"2024-12-31","value":"0.17","vol":"0.88"},{"date":"2024-09-30","value":"0.16","vol":"0.41"},{"date":"2024-06-30","value":"0.16","vol":"0.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.15 | 0.15 | 0.17 | 0.16 | 0.16 |
| 行业(%) | 1.11 | 0.78 | 0.88 | 0.41 | 0.38 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 国泰海通证券 | 2025-09-09 | 买入 | |
| 中信证券 | 2025-09-05 | 买入 | |
| 东方证券 | 2025-09-02 | 买入 | |
| 野村东方国际证券 | 2025-08-27 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"3.91","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"5.87","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.12","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.45","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.68","blueLineValue":"0.91","type":"YC"}]